{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T15:14:15Z","timestamp":1718810055775},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2006,12,20]],"date-time":"2006-12-20T00:00:00Z","timestamp":1166572800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2006,12,20]],"date-time":"2006-12-20T00:00:00Z","timestamp":1166572800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1007\/s00262-006-0267-y","type":"journal-article","created":{"date-parts":[[2006,12,19]],"date-time":"2006-12-19T09:19:26Z","timestamp":1166519966000},"page":"943-957","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Immunotherapy of myeloid leukaemia"],"prefix":"10.1007","volume":"56","author":[{"given":"Barbara-Ann","family":"Guinn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azim","family":"Mohamedali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. Shaun B.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken I.","family":"Mills","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,12,20]]},"reference":[{"key":"267_CR1","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1038\/sj.leu.2402732","volume":"16","author":"SP Adams","year":"2002","unstructured":"Adams SP, Sahota SS, Mijovic A, Czepulkowski B, Padua RA, Mufti GJ, Guinn BA (2002) Frequent expression of HAGE in presentation chronic myeloid leukaemias. Leukemia 16:2238\u20132242","journal-title":"Leukemia"},{"key":"267_CR2","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1182\/blood-2004-07-2548","volume":"105","author":"MH Andersen","year":"2005","unstructured":"Andersen MH, Svane IM, Kvistborg P, Nielsen OJ, Balslev E, Reker S, Becker JC, Straten PT (2005) Immunogenicity of Bcl-2 in patients with cancer. Blood 105:728\u2013734","journal-title":"Blood"},{"key":"267_CR3","doi-asserted-by":"publisher","first-page":"7043","DOI":"10.1158\/1078-0432.CCR-04-0322","volume":"10","author":"J Bae","year":"2004","unstructured":"Bae J, Martinson JA, Klingemann HG (2004) Heteroclitic CD33 peptide with enhanced anti-acute myeloid leukemic immunogenicity. Clin Cancer Res 10:7043\u20137052","journal-title":"Clin Cancer Res"},{"key":"267_CR4","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0140-6736(05)17945-8","volume":"365","author":"M Bocchia","year":"2005","unstructured":"Bocchia M, Gentili S, Abruzzese E, Fanelli A, Iuliano F, Tabilio A, Amabile M, Forconi F, Gozzetti A, Raspadori D, Amadori S, Lauria F (2005) Effect of a p210 multipeptide vaccine associated with imatinib or interferon in patients with chronic myeloid leukaemia and persistent residual disease: a multicentre observational trial. Lancet 365:657\u2013662","journal-title":"Lancet"},{"key":"267_CR5","doi-asserted-by":"crossref","first-page":"6021","DOI":"10.4049\/jimmunol.167.10.6021","volume":"167","author":"AG Buggins","year":"2001","unstructured":"Buggins AG, Milojkovic D, Arno MJ, Lea NC, Mufti GJ, Thomas NS, Hirst WJ (2001) Microenvironment produced by acute myeloid leukemia cells prevents T cell activation and proliferation by inhibition of NF-kappaB, c-Myc, and pRb pathways. J Immunol 167:6021\u20136030","journal-title":"J Immunol"},{"key":"267_CR6","doi-asserted-by":"publisher","first-page":"6296","DOI":"10.1200\/JCO.2005.05.020","volume":"23","author":"L Bullinger","year":"2005","unstructured":"Bullinger L, Valk PJ (2005) Gene expression profiling in acute myeloid leukemia. J Clin Oncol 23:6296\u20136305","journal-title":"J Clin Oncol"},{"key":"267_CR7","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1182\/blood-2003-03-0954","volume":"103","author":"K Cathcart","year":"2004","unstructured":"Cathcart K, Pinilla-Ibarz J, Korontsvit T, Schwartz J, Zakhaleva V, Papadopoulos EB, Scheinberg DA (2004) A multivalent bcr-abl fusion peptide vaccination trial in patients with chronic myeloid leukemia. Blood 103:1037\u20131042","journal-title":"Blood"},{"key":"267_CR8","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/j.1365-2141.1993.tb03111.x","volume":"84","author":"H Chambost","year":"1993","unstructured":"Chambost H, Brasseur F, Coulie P, de Plaen E, Stoppa AM, Baume D, Mannoni P, Boon T, Maraninchi D, Olive D (1993) A tumour-associated antigen expression in human haematological malignancies. Br J Haematol 84:524\u2013526","journal-title":"Br J Haematol"},{"key":"267_CR9","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1038\/sj.leu.2402278","volume":"15","author":"H Chambost","year":"2001","unstructured":"Chambost H, van Baren N, Brasseur F, Olive D (2001) MAGE-A genes are not expressed in human leukemias. Leukemia 15:1769\u20131771","journal-title":"Leukemia"},{"key":"267_CR10","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.ymthe.2004.09.006","volume":"11","author":"L Chan","year":"2005","unstructured":"Chan L, Hardwick N, Darling D, Galea-Lauri J, Gaken J, Devereux S, Kemeny M, Mufti G, Farzaneh F (2005) IL-2\/B7.1 (CD80) fusagene transduction of AML blasts by a self-inactivating lentiviral vector stimulates T cell responses in vitro: a strategy to generate whole cell vaccines for AML. Mol Ther 11:120\u2013131","journal-title":"Mol Ther"},{"key":"267_CR11","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1007\/s00262-006-0129-7","volume":"55","author":"L Chan","year":"2006","unstructured":"Chan L, Hardwick NR, Guinn BA, Darling D, Gaken J, Galea-Lauri J, Ho AY, Mufti GJ, Farzaneh F (2006) An immune edited tumour versus a tumour edited immune system: prospects for immune therapy of acute myeloid leukaemia. Cancer Immunol Immunother 55:1017\u20131024","journal-title":"Cancer Immunol Immunother"},{"key":"267_CR12","doi-asserted-by":"publisher","first-page":"e265","DOI":"10.1371\/journal.pmed.0020265","volume":"2","author":"DS Chen","year":"2005","unstructured":"Chen DS, Soen Y, Stuge TB, Lee PP, Weber JS, Brown PO, Davis MM (2005) Marked differences in human melanoma antigen-specific T cell responsiveness after vaccination using a functional microarray. PLoS Med 2:e265","journal-title":"PLoS Med"},{"key":"267_CR13","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.leukres.2004.09.013","volume":"29","author":"G Chen","year":"2005","unstructured":"Chen G, Zhang W, Cao X, Li F, Liu X, Yao L (2005) Serological identification of immunogenic antigens in acute monocytic leukemia. Leuk Res 29:503\u2013509","journal-title":"Leuk Res"},{"key":"267_CR14","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s00262-005-0674-5","volume":"55","author":"AT Cheuk","year":"2006","unstructured":"Cheuk AT, Chan L, Czepulkowski B, Berger SA, Yagita H, Okumura K, Farzaneh F, Mufti GJ, Guinn BA (2006) Development of a whole cell vaccine for acute myeloid leukaemia. Cancer Immunol Immunother 55:68\u201375","journal-title":"Cancer Immunol Immunother"},{"key":"267_CR15","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.1182\/blood.V98.10.2887","volume":"98","author":"RE Clark","year":"2001","unstructured":"Clark RE, Dodi IA, Hill SC, Lill JR, Aubert G, Macintyre AR, Rojas J, Bourdon A, Bonner PL, Wang L, Christmas SE, Travers PJ, Creaser CS, Rees RC, Madrigal JA (2001) Direct evidence that leukemic cells present HLA-associated immunogenic peptides derived from the BCR-ABL b3a2 fusion protein. Blood 98:2887\u20132893","journal-title":"Blood"},{"key":"267_CR16","doi-asserted-by":"publisher","first-page":"10697","DOI":"10.1073\/pnas.0403572101","volume":"101","author":"ID Davis","year":"2004","unstructured":"Davis ID, Chen W, Jackson H, Parente P, Shackleton M, Hopkins W, Chen Q, Dimopoulos N, Luke T, Murphy R, Scott AM, Maraskovsky E, McArthur G, MacGregor D, Sturrock S, Tai TY, Green S, Cuthbertson A, Maher D, Miloradovic L, Mitchell SV, Ritter G, Jungbluth AA, Chen YT, Gnjatic S, Hoffman EW, Old LJ, Cebon JS (2004) Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4(+) and CD8(+) T cell responses in humans. Proc Natl Acad Sci USA 101:10697\u201310702","journal-title":"Proc Natl Acad Sci USA"},{"key":"267_CR17","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1182\/blood.V96.4.1480","volume":"96","author":"A Gaiger","year":"2000","unstructured":"Gaiger A, Reese V, Disis ML, Cheever MA (2000) Immunity to WT1 in the animal model and in patients with acute myeloid leukemia. Blood 96:1480\u20131489","journal-title":"Blood"},{"key":"267_CR18","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1046\/j.1365-2567.2002.01497.x","volume":"107","author":"J Galea-Lauri","year":"2002","unstructured":"Galea-Lauri J (2002) Immunological weapons against acute myeloid leukaemia. Immunology 107:20\u201327","journal-title":"Immunology"},{"key":"267_CR19","doi-asserted-by":"crossref","first-page":"8210","DOI":"10.4049\/jimmunol.174.12.8210","volume":"174","author":"M Gannage","year":"2005","unstructured":"Gannage M, Abel M, Michallet AS, Delluc S, Lambert M, Giraudier S, Kratzer R, Niedermann G, Saveanu L, Guilhot F, Camoin L, Varet B, Buzyn A, Caillat-Zucman S (2005) Ex vivo characterization of multiepitopic tumor-specific CD8 T cells in patients with chronic myeloid leukemia: implications for vaccine development and adoptive cellular immunotherapy. J Immunol 174:8210\u20138218","journal-title":"J Immunol"},{"key":"267_CR20","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1182\/blood-2004-12-4787","volume":"106","author":"J Greiner","year":"2005","unstructured":"Greiner J, Li L, Ringhoffer M, Barth TF, Giannopoulos K, Guillaume P, Ritter G, Wiesneth M, Dohner H, Schmitt M (2005) Identification and characterization of epitopes of the receptor for hyaluronic acid-mediated motility (RHAMM\/CD168) recognized by CD8+ T cells of HLA-A2-positive patients with acute myeloid leukemia. Blood 106:938\u2013945","journal-title":"Blood"},{"key":"267_CR21","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1016\/S0301-472X(00)00550-6","volume":"28","author":"J Greiner","year":"2000","unstructured":"Greiner J, Ringhoffer M, Simikopinko O, Szmaragowska A, Huebsch S, Maurer U, Bergmann L, Schmitt M (2000) Simultaneous expression of different immunogenic antigens in acute myeloid leukemia. Exp Hematol 28:1413\u20131422","journal-title":"Exp Hematol"},{"key":"267_CR22","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1002\/ijc.11200","volume":"106","author":"J Greiner","year":"2003","unstructured":"Greiner J, Ringhoffer M, Taniguchi M, Hauser T, Schmitt A, Dohner H, Schmitt M (2003) Characterization of several leukemia-associated antigens inducing humoral immune responses in acute and chronic myeloid leukemia. Int J Cancer 106:224\u2013231","journal-title":"Int J Cancer"},{"key":"267_CR23","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1002\/ijc.11623","volume":"108","author":"J Greiner","year":"2004","unstructured":"Greiner J, Ringhoffer M, Taniguchi M, Li L, Schmitt A, Shiku H, Dohner H, Schmitt M (2004) mRNA expression of leukemia-associated antigens in patients with acute myeloid leukemia for the development of specific immunotherapies. Int J Cancer 108:704\u2013711","journal-title":"Int J Cancer"},{"key":"267_CR24","doi-asserted-by":"crossref","unstructured":"Greiner J, Schmitt M, Li L, Giannopoulos K, Bosch K, Schmitt A, Dohner K, Schlenk RF, Pollack JR, Dohner H, Bullinger L (2006) Expression of tumor-associated antigens in acute myeloid leukemia: implications for specific immunotherapeutic approaches. Blood. DOI 10.1182\/blood-2006-01-023127","DOI":"10.1182\/blood-2006-01-023127"},{"key":"267_CR25","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.bbrc.2005.08.024","volume":"335","author":"BA Guinn","year":"2005","unstructured":"Guinn BA, Bland EA, Lodi U, Liggins AP, Tobal K, Petters S, Wells JW, Banham AH, Mufti GJ (2005) Humoral detection of leukaemia-associated antigens in presentation acute myeloid leukaemia. Biochem Biophys Res Commun 335:1293\u20131304","journal-title":"Biochem Biophys Res Commun"},{"key":"267_CR26","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1111\/j.1365-2141.2006.06135.x","volume":"134","author":"BA Guinn","year":"2006","unstructured":"Guinn BA, Gilkes AF, Mufti GJ, Burnett AK, Mills KI (2006) The tumour antigens RAGE-1 and MGEA6 are expressed more frequently in the less lineage restricted subgroups of presentation acute myeloid leukaemia. Br J Haematol 134:238\u2013239","journal-title":"Br J Haematol"},{"key":"267_CR27","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.bbrc.2005.05.161","volume":"333","author":"BA Guinn","year":"2005","unstructured":"Guinn BA, Gilkes AF, Woodward E, Westwood NB, Mufti GJ, Linch D, Burnett AK, Mills KI (2005) Microarray analysis of tumour antigen expression in presentation acute myeloid leukaemia. Biochem Biophys Res Commun 333:703\u2013713","journal-title":"Biochem Biophys Res Commun"},{"key":"267_CR28","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1126\/science.1105436","volume":"307","author":"DA Hinds","year":"2005","unstructured":"Hinds DA, Stuve LL, Nilsen GB, Halperin E, Eskin E, Ballinger DG, Frazer KA, Cox DR (2005) Whole-genome patterns of common DNA variation in three human populations. Science 307:1072\u20131079","journal-title":"Science"},{"key":"267_CR29","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1182\/blood.V84.9.3071.3071","volume":"84","author":"K Inoue","year":"1994","unstructured":"Inoue K, Sugiyama H, Ogawa H, Nakagawa M, Yamagami T, Miwa H, Kita K, Hiraoka A, Masaoka T, Nasu K (1994) WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia. Blood 84:3071\u20133079","journal-title":"Blood"},{"key":"267_CR30","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/nature02168","volume":"426","author":"The International HapMap Project","year":"2003","unstructured":"The International HapMap Project (2003) Nature 426:789\u2013796","journal-title":"Nature"},{"key":"267_CR31","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1007\/s00262-003-0470-z","volume":"53","author":"D Jager","year":"2004","unstructured":"Jager D, Taverna C, Zippelius A, Knuth A (2004) Identification of tumor antigens as potential target antigens for immunotherapy by serological expression cloning. Cancer Immunol Immunother 53:144\u2013147","journal-title":"Cancer Immunol Immunother"},{"key":"267_CR32","doi-asserted-by":"publisher","first-page":"4760","DOI":"10.1073\/pnas.97.9.4760","volume":"97","author":"E Jager","year":"2000","unstructured":"Jager E, Nagata Y, Gnjatic S, Wada H, Stockert E, Karbach J, Dunbar PR, Lee SY, Jungbluth A, Jager D, Arand M, Ritter G, Cerundolo V, Dupont B, Chen YT, Old LJ, Knuth A (2000) Monitoring CD8 T cell responses to NY-ESO-1: correlation of humoral and cellular immune responses. Proc Natl Acad Sci USA 97:4760\u20134765","journal-title":"Proc Natl Acad Sci USA"},{"key":"267_CR33","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.semcancer.2003.11.006","volume":"14","author":"AM John","year":"2004","unstructured":"John AM, Thomas NS, Mufti GJ, Padua RA (2004) Targeted therapies in myeloid leukemia. Semin Cancer Biol 14:41\u201362","journal-title":"Semin Cancer Biol"},{"key":"267_CR34","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1038\/sj.leu.2403946","volume":"19","author":"SH Kaufmann","year":"2005","unstructured":"Kaufmann SH, Steensma DP (2005) On the TRAIL of a new therapy for leukemia. Leukemia 19:2195\u20132202","journal-title":"Leukemia"},{"key":"267_CR35","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1038\/sj.leu.2404234","volume":"20","author":"AJ Knights","year":"2006","unstructured":"Knights AJ, Weinzierl AO, Flad T, Guinn BA, Mueller L, Mufti GJ, Stevanovic S, Pawelec G (2006) A novel MHC-associated proteinase 3 peptide isolated from primary chronic myeloid leukaemia cells further supports the significance of this antigen for the immunotherapy of myeloid leukaemias. Leukemia 20:1067\u20131072","journal-title":"Leukemia"},{"key":"267_CR36","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.beha.2004.06.004","volume":"17","author":"HJ Kolb","year":"2004","unstructured":"Kolb HJ, Rank A, Chen X, Woiciechowsky A, Roskrow M, Schmid C, Tischer J, Ledderose G (2004) In-vivo generation of leukaemia-derived dendritic cells. Best Pract Res Clin Haematol 17:439\u2013451","journal-title":"Best Pract Res Clin Haematol"},{"key":"267_CR37","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1038\/sj.leu.2402582","volume":"16","author":"RC Koya","year":"2002","unstructured":"Koya RC, Kasahara N, Pullarkat V, Levine AM, Stripecke R (2002) Transduction of acute myeloid leukemia cells with third generation self-inactivating lentiviral vectors expressing CD80 and GM-CSF: effects on proliferation, differentiation, and stimulation of allogeneic and autologous anti-leukemia immune responses. Leukemia 16:1645\u20131654","journal-title":"Leukemia"},{"key":"267_CR38","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1056\/NEJMra044389","volume":"353","author":"DS Krause","year":"2005","unstructured":"Krause DS, Van Etten RA (2005) Tyrosine kinases as targets for cancer therapy. N Engl J Med 353:172\u2013187","journal-title":"N Engl J Med"},{"key":"267_CR39","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1007\/s00262-004-0657-y","volume":"54","author":"S Kufner","year":"2005","unstructured":"Kufner S, Fleischer RP, Kroell T, Schmid C, Zitzelsberger H, Salih H, de Valle F, Treder W, Schmetzer HM (2005) Serum-free generation and quantification of functionally active Leukemia-derived DC is possible from malignant blasts in acute myeloid leukemia and myelodysplastic syndromes. Cancer Immunol Immunother 54:953\u2013970","journal-title":"Cancer Immunol Immunother"},{"key":"267_CR40","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s00262-004-0631-8","volume":"54","author":"L Li","year":"2005","unstructured":"Li L, Reinhardt P, Schmitt A, Barth TF, Greiner J, Ringhoffer M, Dohner H, Wiesneth M, Schmitt M (2005) Dendritic cells generated from acute myeloid leukemia (AML) blasts maintain the expression of immunogenic leukemia associated antigens. Cancer Immunol Immunother 54:685\u2013693","journal-title":"Cancer Immunol Immunother"},{"key":"267_CR41","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1182\/blood-2003-07-2585","volume":"104","author":"Y Li","year":"2004","unstructured":"Li Y, Li H, Wang MN, Lu D, Bassi R, Wu Y, Zhang H, Balderes P, Ludwig DL, Pytowski B, Kussie P, Piloto O, Small D, Bohlen P, Witte L, Zhu Z, Hicklin DJ (2004) Suppression of leukemia expressing wild-type or ITD-mutant FLT3 receptor by a fully human anti-FLT3 neutralizing antibody. Blood 104:1137\u20131144","journal-title":"Blood"},{"key":"267_CR42","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1038\/sj.bjc.6690824","volume":"81","author":"SH Lim","year":"1999","unstructured":"Lim SH, Austin S, Owen-Jones E, Robinson L (1999) Expression of testicular genes in haematological malignancies. Br J Cancer 81:1162\u20131164","journal-title":"Br J Cancer"},{"key":"267_CR43","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1056\/NEJM199909303411407","volume":"341","author":"B Lowenberg","year":"1999","unstructured":"Lowenberg B, Downing JR, Burnett A (1999) Acute myeloid leukemia. N Engl J Med 341:1051\u20131062","journal-title":"N Engl J Med"},{"key":"267_CR44","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/nrc1739","volume":"5","author":"JA Ludwig","year":"2005","unstructured":"Ludwig JA, Weinstein JN (2005) Biomarkers in cancer staging, prognosis and treatment selection. Nat Rev Cancer 5:845\u2013856","journal-title":"Nat Rev Cancer"},{"key":"267_CR45","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/sj.leu.2403186","volume":"18","author":"V Mailander","year":"2004","unstructured":"Mailander V, Scheibenbogen C, Thiel E, Letsch A, Blau IW, Keilholz U (2004) Complete remission in a patient with recurrent acute myeloid leukemia induced by vaccination with WT1 peptide in the absence of hematological or renal toxicity. Leukemia 18:165\u2013166","journal-title":"Leukemia"},{"key":"267_CR46","doi-asserted-by":"publisher","first-page":"2742","DOI":"10.1073\/pnas.0530192100","volume":"100","author":"WA Marijt","year":"2003","unstructured":"Marijt WA, Heemskerk MH, Kloosterboer FM, Goulmy E, Kester MG, van der Hoorn MA, van Luxemburg-Heys SA, Hoogeboom M, Mutis T, Drijfhout JW, van Rood JJ, Willemze R, Falkenburg JH (2003) Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia. Proc Natl Acad Sci USA 100:2742\u20132747","journal-title":"Proc Natl Acad Sci USA"},{"key":"267_CR47","first-page":"235","volume":"3","author":"V Mathews","year":"2004","unstructured":"Mathews V, DiPersio JF (2004) Stem cell transplantation in acute myelogenous leukemia in first remission: what are the options? Curr Hematol Rep 3:235\u2013241","journal-title":"Curr Hematol Rep"},{"key":"267_CR48","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1046\/j.1365-2141.2001.02670.x","volume":"112","author":"M Matsushita","year":"2001","unstructured":"Matsushita M, Ikeda H, Kizaki M, Okamoto S, Ogasawara M, Ikeda Y, Kawakami Y (2001) Quantitative monitoring of the PRAME gene for the detection of minimal residual disease in leukaemia. Br J Haematol 112:916\u2013926","journal-title":"Br J Haematol"},{"key":"267_CR49","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1080\/1042819021000035725","volume":"44","author":"M Matsushita","year":"2003","unstructured":"Matsushita M, Yamazaki R, Ikeda H, Kawakami Y (2003) Preferentially expressed antigen of melanoma (PRAME) in the development of diagnostic and therapeutic methods for hematological malignancies. Leuk Lymphoma 44:439\u2013444","journal-title":"Leuk Lymphoma"},{"key":"267_CR50","first-page":"RA194","volume":"12","author":"J Meletis","year":"2006","unstructured":"Meletis J, Viniou N, Terpos E (2006) Novel agents for the management of myelodysplastic syndromes. Med Sci Monit 12:RA194\u2013RA206","journal-title":"Med Sci Monit"},{"key":"267_CR51","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1126\/science.1129003","volume":"314","author":"RA Morgan","year":"2006","unstructured":"Morgan RA, Dudley ME, Wunderlich JR, Hughes MS, Yang JC, Sherry RM, Royal RE, Topalian SL, Kammula US, Restifo NP, Zheng Z, Nahvi A, de Vries CR, Rogers-Freezer LJ, Mavroukakis SA, Rosenberg SA (2006) Cancer regression in patients after transfer of genetically engineered lymphocytes. Science 314:126\u2013129","journal-title":"Science"},{"key":"267_CR52","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.blre.2005.05.001","volume":"20","author":"E Morris","year":"2006","unstructured":"Morris E, Hart D, Gao L, Tsallios A, Xue SA, Stauss H (2006) Generation of tumor-specific T-cell therapies. Blood Rev 20:61\u201369","journal-title":"Blood Rev"},{"key":"267_CR53","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1517\/14712598.4.1.95","volume":"4","author":"DA Mulford","year":"2004","unstructured":"Mulford DA, Jurcic JG (2004) Antibody-based treatment of acute myeloid leukaemia. Expert Opin Biol Ther 4:95\u2013105","journal-title":"Expert Opin Biol Ther"},{"key":"267_CR54","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1053\/shem.2003.50041","volume":"40","author":"R Ohno","year":"2003","unstructured":"Ohno R, Nakamura Y (2003) Prediction of response to imatinib by cDNA microarray analysis. Semin Hematol 40:42\u201349","journal-title":"Semin Hematol"},{"key":"267_CR55","doi-asserted-by":"publisher","first-page":"13885","DOI":"10.1073\/pnas.0405884101","volume":"101","author":"Y Oka","year":"2004","unstructured":"Oka Y, Tsuboi A, Taguchi T, Osaki T, Kyo T, Nakajima H, Elisseeva OA, Oji Y, Kawakami M, Ikegame K, Hosen N, Yoshihara S, Wu F, Fujiki F, Murakami M, Masuda T, Nishida S, Shirakata T, Nakatsuka S, Sasaki A, Udaka K, Dohy H, Aozasa K, Noguchi S, Kawase I, Sugiyama H (2004) Induction of WT1 (Wilms\u2019 tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression. Proc Natl Acad Sci USA 101:13885\u201313890","journal-title":"Proc Natl Acad Sci USA"},{"key":"267_CR56","doi-asserted-by":"publisher","first-page":"5720","DOI":"10.1038\/sj.onc.1206855","volume":"22","author":"J Ota","year":"2003","unstructured":"Ota J, Yamashita Y, Okawa K, Kisanuki H, Fujiwara S, Ishikawa M, Lim Choi Y, Ueno S, Ohki R, Koinuma K, Wada T, Compton D, Kadoya T, Mano H (2003) Proteomic analysis of hematopoietic stem cell-like fractions in leukemic disorders. Oncogene 22:5720\u20135728","journal-title":"Oncogene"},{"key":"267_CR57","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1038\/nm949","volume":"9","author":"RA Padua","year":"2003","unstructured":"Padua RA, Larghero J, Robin M, le Pogam C, Schlageter MH, Muszlak S, Fric J, West R, Rousselot P, Phan TH, Mudde L, Teisserenc H, Carpentier AF, Kogan S, Degos L, Pla M, Bishop JM, Stevenson F, Charron D, Chomienne C (2003) PML-RARA-targeted DNA vaccine induces protective immunity in a mouse model of leukemia. Nat Med 9:1413\u20131417","journal-title":"Nat Med"},{"key":"267_CR58","doi-asserted-by":"crossref","first-page":"4391","DOI":"10.4049\/jimmunol.168.9.4391","volume":"168","author":"MJ Palmowski","year":"2002","unstructured":"Palmowski MJ, Choi EM, Hermans IF, Gilbert SC, Chen JL, Gileadi U, Salio M, Van Pel A, Man S, Bonin E, Liljestrom P, Dunbar PR, Cerundolo V (2002) Competition between CTL narrows the immune response induced by prime-boost vaccination protocols. J Immunol 168:4391\u20134398","journal-title":"J Immunol"},{"key":"267_CR59","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1182\/blood.V95.5.1781.005k46_1781_1787","volume":"95","author":"J Pinilla-Ibarz","year":"2000","unstructured":"Pinilla-Ibarz J, Cathcart K, Korontsvit T, Soignet S, Bocchia M, Caggiano J, Lai L, Jimenez J, Kolitz J, Scheinberg DA (2000) Vaccination of patients with chronic myelogenous leukemia with bcr-abl oncogene breakpoint fusion peptides generates specific immune responses. Blood 95:1781\u20131787","journal-title":"Blood"},{"key":"267_CR60","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1038\/sj.leu.2404380","volume":"20","author":"J Pinilla-Ibarz","year":"2006","unstructured":"Pinilla-Ibarz J, May RJ, Korontsvit T, Gomez M, Kappel B, Zakhaleva V, Zhang RH, Scheinberg DA (2006) Improved human T-cell responses against synthetic HLA-0201 analog peptides derived from the WT1 oncoprotein. Leukemia 20:2025\u20132033","journal-title":"Leukemia"},{"key":"267_CR61","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.beha.2006.05.003","volume":"19","author":"DL Porter","year":"2006","unstructured":"Porter DL, Antin JH (2006) Donor leukocyte infusions in myeloid malignancies: new strategies. Best Pract Res Clin Haematol 19:737\u2013755","journal-title":"Best Pract Res Clin Haematol"},{"key":"267_CR62","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1182\/blood.V104.11.259.259","volume":"104","author":"MH Qazilbash","year":"2004","unstructured":"Qazilbash MH, Wieder E, Rios R, Sijie L, Kant S, Giralt S, Estey EH, Thall P, de Lima M, Couriel D, et al (2004) Vaccination wth the PR1 leukaemia-associated antigen can induce complete remission in patients with myeloid leukaemia. Blood 104:259 (abstract)","journal-title":"Blood"},{"key":"267_CR63","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1158\/0008-5472.375.65.2","volume":"65","author":"M Raghavan","year":"2005","unstructured":"Raghavan M, Lillington DM, Skoulakis S, Debernardi S, Chaplin T, Foot NJ, Lister TA, Young BD (2005) Genome-wide single nucleotide polymorphism analysis reveals frequent partial uniparental disomy due to somatic recombination in acute myeloid leukemias. Cancer Res 65:375\u2013378","journal-title":"Cancer Res"},{"key":"267_CR64","first-page":"73","volume":"4","author":"VL Reichardt","year":"2005","unstructured":"Reichardt VL, Brossart P (2005). Current status of vaccination therapy for leukemias. Curr Hematol Rep 4:73\u201376","journal-title":"Curr Hematol Rep"},{"key":"267_CR65","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1007\/s00262-005-0678-1","volume":"54","author":"M Robin","year":"2005","unstructured":"Robin M, Schlageter MH, Chomienne C, Padua RA (2005) Targeted immunotherapy in acute myeloblastic leukemia: from animals to humans. Cancer Immunol Immunother 54:933\u2013943","journal-title":"Cancer Immunol Immunother"},{"key":"267_CR66","doi-asserted-by":"publisher","first-page":"11810","DOI":"10.1073\/pnas.92.25.11810","volume":"92","author":"U Sahin","year":"1995","unstructured":"Sahin U, Tureci O, Schmitt H, Cochlovius B, Johannes T, Schmits R, Stenner F, Luo G, Schobert I, Pfreundschuh M (1995) Human neoplasms elicit multiple specific immune responses in the autologous host. Proc Natl Acad Sci USA 92:11810\u201311813","journal-title":"Proc Natl Acad Sci USA"},{"key":"267_CR67","first-page":"1","volume":"4","author":"MJ Scanlan","year":"2004","unstructured":"Scanlan MJ, Simpson AJ, Old LJ (2004) The cancer\/testis genes: review, standardization, and commentary. Cancer Immun 4:1","journal-title":"Cancer Immun"},{"key":"267_CR68","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1182\/blood-2002-01-0163","volume":"100","author":"C Scheibenbogen","year":"2002","unstructured":"Scheibenbogen C, Letsch A, Thiel E, Schmittel A, Mailaender V, Baerwolf S, Nagorsen D, Keilholz U (2002) CD8 T-cell responses to Wilms tumor gene product WT1 and proteinase 3 in patients with acute myeloid leukemia. Blood 100:2132\u20132137","journal-title":"Blood"},{"key":"267_CR69","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.leukres.2004.07.005","volume":"29","author":"T Schirrmann","year":"2005","unstructured":"Schirrmann T, Pecher G (2005) Specific targeting of CD33(+) leukemia cells by a natural killer cell line modified with a chimeric receptor. Leuk Res 29:301\u2013306","journal-title":"Leuk Res"},{"key":"267_CR70","first-page":"297","volume":"53","author":"BL Scott","year":"2005","unstructured":"Scott BL, Deeg HJ (2005) Hemopoietic cell transplantation for the myelodysplastic syndromes. Arch Immunol Ther Exp 53:297\u2013307","journal-title":"Arch Immunol Ther Exp"},{"key":"267_CR71","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.semcancer.2005.07.005","volume":"16","author":"P Serafini","year":"2006","unstructured":"Serafini P, Borrello I, Bronte V (2006) Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression. Semin Cancer Biol 16:53\u201365","journal-title":"Semin Cancer Biol"},{"key":"267_CR72","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1038\/sj.leu.2403510","volume":"18","author":"S Siegel","year":"2004","unstructured":"Siegel S, Steinmann J, Schmitz N, Stuhlmann R, Dreger P, Zeis M (2004) Identification of a survivin-derived peptide that induces HLA-A*0201-restricted antileukemia cytotoxic T lymphocytes. Leukemia 18:2046\u20132047","journal-title":"Leukemia"},{"key":"267_CR73","doi-asserted-by":"publisher","first-page":"4416","DOI":"10.1182\/blood-2003-01-0198","volume":"102","author":"S Siegel","year":"2003","unstructured":"Siegel S, Wagner A, Kabelitz D, Marget M, Coggin J Jr, Barsoum A, Rohrer J, Schmitz N, Zeis M (2003) Induction of cytotoxic T-cell responses against the oncofetal antigen-immature laminin receptor for the treatment of hematologic malignancies. Blood 102:4416\u20134423","journal-title":"Blood"},{"key":"267_CR74","doi-asserted-by":"publisher","first-page":"E65","DOI":"10.1371\/journal.pbio.0000065","volume":"1","author":"Y Soen","year":"2003","unstructured":"Soen Y, Chen DS, Kraft DL, Davis MM, Brown PO (2003) Detection and characterization of cellular immune responses using peptide-MHC microarrays. PLoS Biol 1:E65","journal-title":"PLoS Biol"},{"key":"267_CR75","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1038\/sj.leu.2404358","volume":"20","author":"E Tagliafico","year":"2006","unstructured":"Tagliafico E, Tenedini E, Manfredini R, Grande A, Ferrari F, Roncaglia E, Bicciato S, Zini R, Salati S, Bianchi E, Gemelli C, Montanari M, Vignudelli T, Zanocco-Marani T, Parenti S, Paolucci P, Martinelli G, Piccaluga PP, Baccarani M, Specchia G, Torelli U, Ferrari S (2006) Identification of a molecular signature predictive of sensitivity to differentiation induction in acute myeloid leukemia. Leukemia 20:1751\u20131758","journal-title":"Leukemia"},{"key":"267_CR76","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1182\/blood-2004-09-3663","volume":"106","author":"T Tsuji","year":"2005","unstructured":"Tsuji T, Yasukawa M, Matsuzaki J, Ohkuri T, Chamoto K, Wakita D, Azuma T, Niiya H, Miyoshi H, Kuzushima K, Oka Y, Sugiyama H, Ikeda H, Nishimura T (2005) Generation of tumor-specific, HLA class I-restricted human Th1 and Tc1 cells by cell engineering with tumor peptide-specific T-cell receptor genes. Blood 106:470\u2013476","journal-title":"Blood"},{"key":"267_CR77","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1038\/sj.leu.2403930","volume":"19","author":"A Van Driessche","year":"2005","unstructured":"Van Driessche A, Gao L, Stauss HJ, Ponsaerts P, Van Bockstaele DR, Berneman ZN, Van Tendeloo VF (2005) Antigen-specific cellular immunotherapy of leukemia. Leukemia 19:1863\u20131871","journal-title":"Leukemia"},{"key":"267_CR78","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1182\/blood-2002-04-1199","volume":"100","author":"JW Vardiman","year":"2002","unstructured":"Vardiman JW, Harris NL, Brunning RD (2002) The World Health Organization (WHO) classification of the myeloid neoplasms. Blood 100:2292\u20132302","journal-title":"Blood"},{"key":"267_CR79","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1038\/sj.leu.2404197","volume":"20","author":"R Villuendas","year":"2006","unstructured":"Villuendas R, Steegmann JL, Pollan M, Tracey L, Granda A, Fernandez-Ruiz E, Casado LF, Martinez J, Martinez P, Lombardia L, Villalon L, Odriozola J, Piris MA (2006) Identification of genes involved in imatinib resistance in CML: a gene-expression profiling approach. Leukemia 20:1047\u20131054","journal-title":"Leukemia"},{"key":"267_CR80","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.critrevonc.2005.06.007","volume":"57","author":"C Walz","year":"2006","unstructured":"Walz C, Sattler M (2006) Novel targeted therapies to overcome imatinib mesylate resistance in chronic myeloid leukemia (CML). Crit Rev Oncol Hematol 57:145\u2013164","journal-title":"Crit Rev Oncol Hematol"},{"key":"267_CR81","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1182\/blood-2002-06-1930","volume":"101","author":"Z Wang","year":"2003","unstructured":"Wang Z, Zhang Y, Liu H, Salati E, Chiriva-Internati M, Lim SH (2003) Gene expression and immunologic consequence of SPAN-Xb in myeloma and other hematologic malignancies. Blood 101:955\u2013960","journal-title":"Blood"},{"key":"267_CR82","doi-asserted-by":"publisher","first-page":"6544","DOI":"10.1158\/1078-0432.CCR-04-0911","volume":"10","author":"Z Wang","year":"2004","unstructured":"Wang Z, Zhang Y, Mandal A, Zhang J, Giles FJ, Herr JC, Lim SH (2004) The spermatozoa protein, SLLP1, is a novel cancer-testis antigen in hematologic malignancies. Clin Cancer Res 10:6544\u20136550","journal-title":"Clin Cancer Res"},{"key":"267_CR83","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S1079-9796(03)00064-0","volume":"31","author":"TL Whiteside","year":"2003","unstructured":"Whiteside TL, Gooding W (2003) Immune monitoring of human gene therapy trials: potential application to leukemia and lymphoma. Blood Cells Mol Dis 31:63\u201371","journal-title":"Blood Cells Mol Dis"},{"key":"267_CR84","doi-asserted-by":"publisher","first-page":"3062","DOI":"10.1182\/blood-2005-01-0146","volume":"106","author":"SA Xue","year":"2005","unstructured":"Xue SA, Gao L, Hart D, Gillmore R, Qasim W, Thrasher A, Apperley J, Engels B, Uckert W, Morris E, Stauss H (2005) Elimination of human leukemia cells in NOD\/SCID mice by WT1-TCR gene-transduced human T cells. Blood 106:3062\u20133067","journal-title":"Blood"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-006-0267-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00262-006-0267-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-006-0267-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-006-0267-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T05:29:51Z","timestamp":1683696591000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00262-006-0267-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12,20]]},"references-count":84,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["267"],"URL":"https:\/\/doi.org\/10.1007\/s00262-006-0267-y","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,12,20]]},"assertion":[{"value":"9 October 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2006","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2006","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}